IL1B and asthma: Upregulated miR-200a/200b expression could inhibit the ERK/MMP-9 pathway by targeting orosomucoid 1-like 3 (ORMDL3), reduce the secretion of TNF-α, IL-1β, -4, -5 and -13, and slow down the development of asthma-related inflammation [36].